Douglas Hughes
Direktor/Vorstandsmitglied bei IMMUNOVANT, INC.
Vermögen: 2 Mio $ am 31.01.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jee Shin | F | - |
Calyxo, Inc.
 Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| George Migausky | M | 69 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 Jahre |
| Atul Pande | M | 69 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 Jahre |
| Peter Salzmann | M | 56 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 Jahre |
| Andrew Fromkin | M | 58 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 Jahre |
| Frank Torti | M | 45 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | 5 Jahre |
| Julia G. Butchko | M | 53 | 5 Jahre | |
| Eva Barnett | F | 44 | 3 Jahre | |
| Mark Levine | M | 51 | 2 Jahre | |
| Ian Gourley | M | - | - | |
| Sheetal Patel | F | - | - | |
| Maria Alba | M | - | - | |
| Judy Roth | F | - | - | |
| Jennifer Moseley | F | - | - | |
| Lauren Schrier | F | - | - | |
| Karr Narula | M | 44 | 2 Jahre | |
| Michael Elliott | M | - | 4 Jahre | |
| Fred Knight | M | - | 2 Jahre | |
| Trit Garg | M | 34 | 2 Jahre | |
| Eric Venker | M | 37 | 4 Jahre | |
| Douglas Hughes | M | - |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Beverly A. Huss | F | 64 |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Jay Stout | M | 61 | 1 Jahre | |
| Robert Goforth | M | - |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Justin Sabet-Peyman | M | 41 | 2 Jahre | |
| William L. Macias | M | 66 | 3 Jahre | |
| Theodore M. Bender | M | - |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | 11 Jahre |
| Joseph Catanese | M | - |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Chau Cheng | M | - | - | |
| Ryan Drant | M | 53 |
Calyxo, Inc.
Calyxo, Inc. Medical SpecialtiesHealth Technology Calyxo, Inc. engages in the manufacture of medical device for kidney stone disease treatment. It also offers research and development. The company was founded in February 2016 and is headquartered in Pleasanton, CA. | - |
| Donald Spence | M | 70 | 2 Jahre | |
| Andy Deig | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| David Amerson | M | - |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Joshua Makower | M | 60 | 7 Jahre | |
| Robert D. Mitchell | M | 62 |
Nellix, Inc.
 Nellix, Inc. Medical SpecialtiesHealth Technology Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA. | 2 Jahre |
| Brooke Seawell | M | 76 | 2 Jahre | |
| Pamela Connealy | F | 62 | 2 Jahre | |
| Geoff B. Pardo | M | 52 | 1 Jahre | |
| Peter Bisgaard | M | 50 | 5 Jahre | |
| Katherine Bayne | F | 57 | - | |
| Nina Richardson | F | 65 | 2 Jahre | |
| Sandeep Kulkarni | M | 43 | 2 Jahre | |
| John Strumbos | M | - | 2 Jahre | |
| Tracy Newbold | F | - | - | |
| Ajit Pillaiu | M | - | 5 Jahre | |
| Rita Jain | M | 62 | - | |
| Tyler Binney | M | - |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Jason Throne | M | 53 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | 2 Jahre |
| Wendy J. Sawyer | F | - |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Juliet Bakker | F | 62 | 1 Jahre | |
| William M. Facteau | M | 53 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| Guido Neels | M | 75 |
Nellix, Inc.
Nellix, Inc. Medical SpecialtiesHealth Technology Nellix, Inc. develops novel solutions to vascular diseases. It develops endograft products for the treatment of abdominal aortic aneurysms and thoracic aortic aneurysms. The company was founded in 2001 and is headquartered in Palo Alto, CA. | 4 Jahre |
| Kevin O'Boyle | M | 68 |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | - |
| W. Middlekauff | M | 63 | 1 Jahre | |
| Myrtle Potter | F | 65 | - | |
| Tom Dorney | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 56 | 100,00% |
| Bermuda | 5 | 8,93% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Douglas Hughes
- Persönliches Netzwerk
